Clinical Trials Browser

Phase 2 × Hodgkin Disease × bryostatin 1 × Clear all

NCT00003936 2014-04-11

Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Phase 2 Completed

Hodgkin Disease, Lymphoma